Coming from developer Noice2D Game, Klee: Spacetime Cleaners is an upcoming auto-shooter game for mobile that’s set to hit both Google Play and the App Store next week on the 9th of January. Check out its trailer below:

The setting of Klee is an alien planet that’s suffering from a severe energy crisis. Controlling the titular Klee and its several companions, you’ll travel back in time in order to retrieve unstable energy cores for recycling. These cores take on the form of monstrous creatures that have to be defeated to restore the planet to its former glory.

The gameplay, meanwhile, focuses mainly on jumping and platforming to dodge enemy blows as the shooting is carried out automatically. There are 3 on-screen buttons for you to control Klee's movements.

Klee
The shooting is done automatically, and you'll focus mainly on dodging enemy blows

The game also features several different items as well as other characters to collect. By combining with these characters, you will be able to alter the natural maneuverability of Klee. According to the developer, this is intended as a way to enable distinctive playstyles, so it's probably worth trying out several different combinations to find the one that suits you most.

At launch, Klee: Spacetime Cleaners will have 2 primary game modes for you to enjoy: The story mode and Infinity, an endless mode in which you try to get as far as you can with only 1 HP. There’s a leaderboard to keep track of your progress and compare it with other players as well, so if you are the competitive sort, this might be the experience that you’ll like.

Klee 2
Several characters and game modes to play with

Visually speaking, the game boasts a lovely retro aesthetic, and the music sounds pretty nice as well. So if the gameplay manages to deliver, this will be a solid auto-shooter to kill our time with.

Klee: Spacetime Cleaners is set to launch for both Android and iOS on January 9th with pre-registration already available right now if you are interested. It’ll be a free-to-play game with IAPs.